Dimensional Fund Advisors
OCUL icon

Dimensional Fund Advisors’s Ocular Therapeutix OCUL Stock Holding History

Dimensional Fund Advisors’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.7M Buy
2,961,781
+178,414
+6% +$1.75M ﹤0.01% 1952
2026
Q2 		$27.3M Buy
2,783,367
+2,133,611
+328% +$19.3M 0.01% 1899
2026
Q1 		$5.49M Buy
+649,756
New +$6.19M ﹤0.01% 2468
2024
Q1 		– Sell
-12,389
Closed -$55.3K – 3422
2023
Q4 		$55.3K Hold
12,389
– – ﹤0.01% 3341
2023
Q3 		$38.9K Sell
12,389
-11,930
-49% -$48.8K ﹤0.01% 3399
2023
Q2 		$125K Hold
24,319
– – ﹤0.01% 3299
2023
Q1 		$128K Buy
+24,319
New +$115K ﹤0.01% 3273
2022
Q3 		$607K Buy
146,122
+38,310
+36% +$193K ﹤0.01% 2998
2022
Q2 		$434K Buy
107,812
+91,089
+545% +$344K ﹤0.01% 3095
2022
Q1 		$83K Hold
16,723
– – ﹤0.01% 3413
2021
Q4 		$117K Buy
+16,723
New +$130K ﹤0.01% 3415
2019
Q4 		– Sell
-11,423
Closed -$35K – 3400
2019
Q3 		$35K Hold
11,423
– – ﹤0.01% 3401
2019
Q2 		$50K Sell
11,423
-12,408
-52% -$45.9K ﹤0.01% 3427
2019
Q1 		$95K Hold
23,831
– – ﹤0.01% 3379
2018
Q4 		$95K Sell
23,831
-5,259
-18% -$29K ﹤0.01% 3360
2018
Q3 		$200K Buy
+29,090
New +$183K ﹤0.01% 3308
2018
Q1 		– Sell
-39,664
Closed -$177K – 3355
2017
Q4 		$177K Hold
39,664
– – ﹤0.01% 3235
2017
Q3 		$245K Buy
+39,664
New +$255K ﹤0.01% 3193

Other funds holding OCUL

Deltec Asset Management
Deltec Asset Management New York $642M AUM 16.66% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Kraematon Investment Advisors
Kraematon Investment Advisors Braintree, Massachusetts $134M AUM 18.69% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Courier Capital
Courier Capital Buffalo, New York $2.02B AUM 16.74% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Dimensional Fund Advisors's OCUL Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Ocular Therapeutix (OCUL) stake by 6.4% in Q3 2026, buying an estimated $1.75M and bringing the position to 2,961,781 shares worth $22.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1952.

Dimensional Fund Advisors first reported a position in OCUL in Q3 2017 and has held it in 18 quarters since. The position peaked at $27.3M in Q2 2026. 66 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • Dimensional Fund Advisors held 2,961,781 shares of Ocular Therapeutix worth $22.7M as of Q3 2026.
  • Dimensional Fund Advisors bought 178,414 Ocular Therapeutix shares in Q3 2026, an estimated $1.75M.
  • Ocular Therapeutix made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #1952 holding.
  • Dimensional Fund Advisors first reported a position in Ocular Therapeutix in Q3 2017 and has held it in 18 quarters since.
  • Dimensional Fund Advisors's Ocular Therapeutix position peaked at $27.3M in Q2 2026.
  • 66 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.